Publicité
Publicité
CNSP
CNS Pharmaceuticals, Inc. Common Stock
6.05
USDSponsorisé
+0.11
+1.94%
09 janv., 15:59 UTC -5
Fermé
Après-marché
6.05
-0.01
-0.15%
CNSP Rapports sur les bénéfices
Ratio de surprise positive
CNSP a dépassé 7 des 17 dernières estimations.
41%
Prochain rapport
Date du prochain rapport
30 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$5.83
Variation implicite de Q3 25 (Revenue/ EPS)
--
/+1.22%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-94.75%
CNS Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 14 nov. 2025, CNSP reported earnings of -5.76 USD per share (EPS) for Q3 25, beating the estimate of -7.23 USD, resulting in a 20.41% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.90% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analystes forecast an EPS of -5.83 USD, with revenue projected to reach -- USD, implying an hausse of 1.22% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
What were CNS Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CNS Pharmaceuticals, Inc. Common Stock reported EPS of -$5.76, beating estimates by 20.41%, and revenue of $0.00, 0% as expectations.
How did the market react to CNS Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.9%, changed from $6.90 before the earnings release to $6.70 the day after.
When is CNS Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30 mars 2026.
What are the forecasts for CNS Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 4
analystes, CNS Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$5.83 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité